Results 1 to 10 of about 131,343 (218)

Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies. [PDF]

open access: yesPLoS ONE, 2016
A large fraction of the patients with rheumatoid arthritis (RA) develop specific autoantibodies, which until recently were only of two types, rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA).
Ariana Montes   +5 more
doaj   +11 more sources

Anti-carbamylated protein antibodies in systemic sclerosis [PDF]

open access: yesArthritis Research & Therapy, 2023
Background To investigate the presence of different isotypes of anti-carbamylated protein (CarP) antibodies in systemic sclerosis (SSc) patients and its association with skin involvement.
Sophie I. E. Liem   +8 more
doaj   +6 more sources

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies [PDF]

open access: yesScientific Reports, 2021
The initial management of rheumatoid arthritis (RA) has a high impact on disease prognosis. Therefore, we need to select the most appropriate treatment as soon as possible. This goal requires biomarkers of disease severity and prognosis.
Cristina Regueiro   +10 more
doaj   +7 more sources

Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus [PDF]

open access: yesArthritis Research & Therapy, 2018
Background The application of more sensitive imaging techniques, such as ultrasonography (US), changed the concept of non-erosive arthritis in systemic lupus erythematosus (SLE), underlining the need for biomarkers to identify patients developing the ...
Fulvia Ceccarelli   +11 more
doaj   +6 more sources

Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis [PDF]

open access: yesArthritis Research & Therapy, 2017
Background Rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and anti-carbamylated protein (anti-CarP) antibodies are rheumatoid arthritis (RA)-associated autoantibodies. Besides their presence in human serum, anti-CarP antibodies have
Marije K. Verheul   +4 more
doaj   +7 more sources

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients [PDF]

open access: yesScientific Reports, 2017
Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics.
Cristina Regueiro   +9 more
doaj   +7 more sources

Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. [PDF]

open access: yesPLoS ONE, 2018
Carbamylation is a post-translational modification that mostly affects proteins with low turnover, such as dermal proteins. Carbamylated proteins accumulate in skin in an age-dependent manner, contributing to tissue alterations.
Elvira Favoino   +6 more
doaj   +7 more sources

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients [PDF]

open access: yesArthritis Research & Therapy, 2017
Background Anti-carbamylated protein (anti-CarP) antibodies have recently been reported to occur in around 45% of rheumatoid arthritis (RA) patients and to have prognostic and diagnostic properties.
Myrthe A. M. van Delft   +8 more
doaj   +7 more sources

Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis [PDF]

open access: yesBMC Musculoskeletal Disorders, 2022
Objective Rheumatoid arthritis (RA) is often complicated with chronic lung diseases (CLD), including interstitial lung disease (ILD) and airway disease, which occur as extra-articular manifestations.
Shomi Oka   +13 more
doaj   +3 more sources

Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients. [PDF]

open access: yesPLoS ONE, 2018
Rheumatoid arthritis (RA) has a negative impact on bone that is partly mediated by anti-citrullinated proteins antibodies (ACPA). These antibodies are associated with erosions, and with juxta-articular and systemic bone loss. Other RA autoantibodies, the
Cristina Regueiro   +5 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy